Lifecore Biomedical

Lifecore Biomedical

Yahoo Finance • 30 days ago

Core Thesis on Lifecore Biomedical (LFCR): Monetizing Excess Production

Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating pro... Full story

Yahoo Finance • last month

Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Manager of Investor Relations - Stephanie Diaz President and Chief Executive Officer - Paul Josephs Chief Financial Officer - Ryan Lake Full... Full story

Yahoo Finance • last month

Lifecore Biomedical Q2 Earnings Call Highlights

Key Points Interested in Lifecore Biomedical, Inc.? Here are five stocks we like better. Lifecore reaffirmed its 2026 guidance for revenue of $120 million to $125 million and adjusted EBITDA of $20.5 million to $25 million, despite second... Full story

Yahoo Finance • last month

Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update

-- Reaffirms 2026 Guidance -- -- Multiple New Business Wins, Adding Impactful Programs to Pipeline -- -- Cost Reduction and Productivity Enhancements Continue to Strengthen Organization -- Conference Call Today at 8:00am ET CHASKA, Min... Full story

Yahoo Finance • 2 months ago

Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026

CHASKA, Minn., July 29, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that it will report fina... Full story

Yahoo Finance • 2 months ago

Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market

Laughing Water Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The second quarter was exceptionally good for the portfolio, with Class A investment i... Full story

Yahoo Finance • 3 months ago

Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations?

We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Lifecore Biomedical, Inc. (NASDAQ:LFCR) is one of the best low-priced pharma stocks on this list. TheFly reported on June 16 that Barrington increased i... Full story

Yahoo Finance • 4 months ago

Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference

CHASKA, Minn., May 21, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will par... Full story

Yahoo Finance • 4 months ago

Lifecore Biomedical Q1 Earnings Call Highlights

Lifecore Biomedical logo Key Points Management added three commercial site transfer programs in Q1 — including a U.S. aesthetics transfer and two CDMO agreements (one ophthalmic expansion) — and expects these to generate commercial reven... Full story

Yahoo Finance • 5 months ago

Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR)

Laughing Water Capital, an investment management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Class A investment in Laughing Water Capital returned approximately -4.5% net of al... Full story

Yahoo Finance • 6 months ago

Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer

-- Site Transfer Agreement for the Manufacture of Commercially Marketed Product -- -- Second Agreement Supports the Expansion of Product Commercially Manufactured at Lifecore to a New Delivery System -- -- Fourth Commercial Site Transfer... Full story

Yahoo Finance • 6 months ago

Lifecore Biomedical Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, March 16, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Lifecore Biomedical, Inc. The investigation focuses on Lifecore Biomedical executive officers and whether inve... Full story

Yahoo Finance • 6 months ago

Lifecore Biomedical Q4 Earnings Call Highlights

Lifecore Biomedical logo Key Points Revenue and profitability improved: Q4 revenue rose to $35.7M (up 10%) and seven-month transition revenue was $75.5M (up 20%), while gross margin climbed to 31% and adjusted EBITDA increased to $8.6M f... Full story

Yahoo Finance • 6 months ago

Lifecore Biomedical GAAP EPS of -$0.16, revenue of $35.75M

* Lifecore Biomedical press release [https://seekingalpha.com/pr/20438291-lifecore-biomedical-reports-financial-results-for-the-fourth-quarter-and-transition-period] (LFCR [https://seekingalpha.com/symbol/LFCR]): Q4 GAAP EPS of -$0.16.... Full story

Yahoo Finance • 6 months ago

Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag

Information technology, industrials and utilities are set to feature prominently in this week’s earnings calendar, with 249 companies scheduled to report. This week’s quant rankings highlight strong momentum among technology and industria... Full story

Yahoo Finance • 7 months ago

Lifecore Biomedical to Participate at DCAT Week 2026

CHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will pa... Full story

Yahoo Finance • 9 months ago

Important Notice to Long-Term Shareholders of CarMax, Inc. (NYSE: KMX); Inspire Medical Systems, Inc. (NYSE: INSP); Integer Holdings Corp. (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, Dec. 31, 2025 (GLOBE NEWSWIRE) -- CarMax, Inc. (NYSE: KMX): Grabar Law Office is investigating claims on behalf of shareholders of CarMax, Inc. (NYSE: KMX). The investigation concerns whether certain officers and director... Full story

Yahoo Finance • 9 months ago

Lifecore Biomedical to be Added to Nasdaq Biotech Index

Lifecore Biomedical, Inc. CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has... Full story

Yahoo Finance • 9 months ago

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer 

Agreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product Partner’s Program Size Positions it to Become a Top Five Commercial Customer for Lifecore CHASKA,... Full story

Yahoo Finance • 10 months ago

Here’s the Analysis of LifeCore’s (LFCR) Growth Potential

Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund returned approximately -9%, bringing the YTD returns to... Full story